BlossomHill Therapeutics, Inc. (BLSM)

BlossomHill Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BlossomHill Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-71.09	-60.56	-30.7
Depreciation & Amortization	0.48	0.44	0.35
Share-Based Compensation	-	1.09	0.5
Other Operating Activities	13.72	12.1	-1.58
Operating Cash Flow	-56.89	-46.93	-31.42
Capital Expenditures	-0.68	-1.07	-0.09
Investing Cash Flow	-0.68	-1.07	-0.09
Share Issuance / Repurchase	-	84.53	17.56
Financing Cash Flow	84.76	84.53	17.56
Net Cash Flow	27.2	36.54	-13.95
Free Cash Flow	-57.56	-47.99	-31.51